These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 32638065)

  • 1. The impact of the duration of HAART on cytokine profiles in pregnancy.
    Sebitloane HM; Naicker T; Moodley J
    Inflamm Res; 2020 Oct; 69(10):1053-1058. PubMed ID: 32638065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women.
    Fiore S; Newell ML; Trabattoni D; Thorne C; Gray L; Savasi V; Tibaldi C; Ferrazzi E; Clerici M
    J Reprod Immunol; 2006 Jun; 70(1-2):143-50. PubMed ID: 16423410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-Inflammatory Cytokine Levels in HIV Infected and Uninfected Pregnant Women with and without Preeclampsia.
    Maharaj NR; Phulukdaree A; Nagiah S; Ramkaran P; Tiloke C; Chuturgoon AA
    PLoS One; 2017; 12(1):e0170063. PubMed ID: 28095491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy in South African women.
    Akoto C; Norris SA; Hemelaar J
    Sci Rep; 2021 May; 11(1):10079. PubMed ID: 33980919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal Th1/Th2 cytokines in preeclampsia and HIV-positive preeclamptic women on highly active anti-retroviral therapy.
    Pillay P; Moodley K; Vatish M; Moodley J; Duarte R; Mackraj I
    Cytokine; 2020 Jan; 125():154795. PubMed ID: 31398625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mother-to-Child Transmission Study in Nigeria: The Impact of Maternal HIV Infection and HAART on Plasma Immunoglobulins, Cytokine Profiles and Infant Outcome.
    Ewenighi-Amankwah CO; Onyenekwe CC; Udemba O; Muogbo P; Rong L
    Virol Sin; 2020 Aug; 35(4):468-477. PubMed ID: 32157604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of highly active antiretroviral therapy on obstetric conditions: A review.
    Sebitloane HM; Moodley D
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():126-131. PubMed ID: 28013100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers.
    Phoswa WN; Naicker T; Ramsuran V; Moodley J
    Inflamm Res; 2019 Jan; 68(1):47-57. PubMed ID: 30276649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine profiles in highly active antiretroviral treatment non-adherent, adherent and naive HIV-1 infected patients in Western Kenya.
    Musa F; Shaviya N; Mambo F; Abonyo C; Barasa E; Wafula P; Sowayi G; Barasa M; Were T
    Afr Health Sci; 2021 Dec; 21(4):1584-1592. PubMed ID: 35283948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects.
    Osuji FN; Onyenekwe CC; Ahaneku JE; Ukibe NR
    J Biomed Sci; 2018 Dec; 25(1):88. PubMed ID: 30501642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-7 and immunologic failure despite treatment with highly active antiretroviral therapy in children perinatally infected with HIV-1.
    Chiappini E; Galli L; Azzari C; de Martino M
    J Acquir Immune Defic Syndr; 2003 Aug; 33(5):601-4. PubMed ID: 12902804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery.
    Boer K; Nellen JF; Patel D; Timmermans S; Tempelman C; Wibaut M; Sluman MA; van der Ende ME; Godfried MH
    BJOG; 2007 Feb; 114(2):148-55. PubMed ID: 17305888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study.
    Ejigu Y; Magnus JH; Sundby J; Magnus MC
    BMJ Open; 2019 Aug; 9(8):e027344. PubMed ID: 31383698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of mean corpuscular volume (MCV) between thalassemia-carrier and non-thalassemia-carrier pregnant women receiving highly active antiretroviral therapy (HAART).
    Thongyou Y; Tongprasert F
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):736-739. PubMed ID: 29241911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HIV and highly active antiretroviral therapy with clinical and biochemical indices among women with pre-eclampsia.
    Maharaj NR; Moodley J; Chuturgoon A
    Int J Gynaecol Obstet; 2016 Sep; 134(3):304-8. PubMed ID: 27350229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
    Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.